ClinicalTrials.Veeva

Menu

Dengue - Sample Collection Study Pakistan

Abbott logo

Abbott

Status

Not yet enrolling

Conditions

Dengue

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT07203183
SDRD-K-029-P

Details and patient eligibility

About

The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.

Enrollment

200 estimated patients

Sex

All

Ages

12+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥12-years-old
  • Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial.

Exclusion criteria

  • Subject has been vaccinated for dengue.
  • Subject participates in an investigative drug, vaccine or medical device clinical study
  • Participant is deemed unfit for the study by the Investigator
  • Participant is unwilling or unable to provide informed consent

Trial design

200 participants in 2 patient groups

dengue positives
dengue negatives

Trial contacts and locations

0

Loading...

Central trial contact

Jocelyn Farge, MSc, MBA; Simon Kordowich, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems